{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:52:47Z","timestamp":1790599967959,"version":"4.1.0"},"reference-count":33,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This work aimed to compare the performance of\n                    <jats:italic>trans<\/jats:italic>\n                    -ferulic acid-encapsulated nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs) for transport by Caco-2 cells. The NLC particles (diameter: 102.6 nm) composed of Compritol\n                    <jats:sup>\u00ae<\/jats:sup>\n                    888 ATO, ethyl oleate, Cremophor\n                    <jats:sup>\u00ae<\/jats:sup>\n                    EL, and Transcutol\n                    <jats:sup>\u00ae<\/jats:sup>\n                    P were larger than the SLNs (diameter: 86.0 nm) formed without liquid lipid (ethyl oleate), and the former had a higher encapsulation efficiency for\n                    <jats:italic>trans<\/jats:italic>\n                    -ferulic acid (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05).\n                    <jats:italic>In vitro<\/jats:italic>\n                    cultured Caco-2 cell transport was used to simulate intestinal absorption, and the cellular uptake of NLCs was higher than that of SLNs (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05). Compared to SLNs, NLCs greatly enhanced\n                    <jats:italic>trans<\/jats:italic>\n                    -ferulic acid permeation through the Millicell\n                    <jats:sup>TM<\/jats:sup>\n                    membrane (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05). This work confirms that NLCs have better properties than SLNs in terms of increasing drug transport by Caco-2 cells. This helps to comprehend the approach by which NLC-mediated oral bioavailability of\n                    <jats:italic>trans<\/jats:italic>\n                    -ferulic acid is better than that mediated by SLNs, as shown in our previous report.\n                  <\/jats:p>","DOI":"10.2478\/acph-2023-0009","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:29:18Z","timestamp":1674559758000},"page":"133-143","source":"Crossref","is-referenced-by-count":5,"title":["Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance\n                    <i>trans<\/i>\n                    -ferulic acid delivery by Caco-2 cells superior to solid lipid nanoparticles"],"prefix":"10.2478","volume":"73","author":[{"given":"Hongyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-2941","authenticated-orcid":false,"given":"Nianping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-4868","authenticated-orcid":false,"given":"Yongtai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional Chinese Medicine , Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"2026051108200792036_j_acph-2023-0009_ref_001","doi-asserted-by":"crossref","unstructured":"1. Y. Liu, Z. Jiang, X. Hou, X. Xie, J. Shi, J. Shen, Y. He, Z. Wang and N. Feng, Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport, Nanomedicine 21 (2019) Article ID 102075; https:\/\/doi.org\/10.1016\/j.nano.2019.10207531377378","DOI":"10.1016\/j.nano.2019.102075"},{"key":"2026051108200792036_j_acph-2023-0009_ref_002","doi-asserted-by":"crossref","unstructured":"2. J. Akbari, M. Saeedi, F. Ahmadi, S. M. H. Hashemi, A. Babaei, S. Yaddollahi, S. S. Rostamkalaei, K. Asare-Addo and A. Nokhodchi, Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration, Pharm Dev. Technol. 27(5) (2022) 525\u2013544; https:\/\/doi.org\/10.1080\/10837450.2022.208455435635506","DOI":"10.1080\/10837450.2022.2084554"},{"key":"2026051108200792036_j_acph-2023-0009_ref_003","doi-asserted-by":"crossref","unstructured":"3. Y. R. Neupane, M. D. Sabir, N. Ahmad, M. Ali and K. Kohli, Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies, Nano-technology 24(41) (2013) Article ID 415102; https:\/\/doi.org\/10.1088\/0957-4484\/24\/41\/41510224061410","DOI":"10.1088\/0957-4484\/24\/41\/415102"},{"key":"2026051108200792036_j_acph-2023-0009_ref_004","doi-asserted-by":"crossref","unstructured":"4. Q. Xia, A. Saupe, R. H. M\u00fcller and E. B. Souto, Nanostrucured lipid carriers as novel carrier for sunscreen formulations, Int. J. Cosmet. Sci. 29(6) (2007) 473\u2013482; https:\/\/doi.org\/10.1111\/j.1468-2494.2007.00410.x18489386","DOI":"10.1111\/j.1468-2494.2007.00410.x"},{"key":"2026051108200792036_j_acph-2023-0009_ref_005","doi-asserted-by":"crossref","unstructured":"5. R. Augustine, A. A. Mamun, A. Hasan, S. A. Salam, R. Chandrasekaran, R. Ahmed and A. S. Thakor, Imaging cancer cells with nanostructures: Prospects of nanotechnology driven non-invasive cancer diagnosis, Adv. Colloid Interface Sci. 294 (2021) Article ID 102457; https:\/\/doi.org\/10.1016\/j.cis.2021.10245734144344","DOI":"10.1016\/j.cis.2021.102457"},{"key":"2026051108200792036_j_acph-2023-0009_ref_006","doi-asserted-by":"crossref","unstructured":"6. H. Liu, Z. Cai, F. Wang, L. Hong, L. Deng, J. Zhong, Z. Wang and W. Cui, Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora, Adv. Sci. (Weinheim) 8(18) (2021) e2101619 (12 pages); https:\/\/doi.org\/10.1002\/advs.202101619845627334292669","DOI":"10.1002\/advs.202101619"},{"key":"2026051108200792036_j_acph-2023-0009_ref_007","doi-asserted-by":"crossref","unstructured":"7. X. Zheng, C. Qiu, J. Long, A. Jiao, X. Xu, Z. Jin and J. Wang, Preparation and characterization of porous starch\/beta-cyclodextrin microsphere for loading curcumin: Equilibrium, kinetics and mechanism of adsorption, Food Biosci. 41 (2021) Article ID 101081; https:\/\/doi.org\/10.1016\/j.fbio.2021.101081","DOI":"10.1016\/j.fbio.2021.101081"},{"key":"2026051108200792036_j_acph-2023-0009_ref_008","doi-asserted-by":"crossref","unstructured":"8. M. Fr\u00fchbauerov\u00e1, L. \u010cervenka, T. H\u00e1jek, M. Pouzar and J. Palar\u010d\u00edk, Bioaccessibility of phenolics from carob (Ceratonia siliqua L.) pod powder prepared by cryogenic and vibratory grinding, Food Chem. 377 (2022) Article ID 131968; https:\/\/doi.org\/10.1016\/j.foodchem.2021.13196834995960","DOI":"10.1016\/j.foodchem.2021.131968"},{"key":"2026051108200792036_j_acph-2023-0009_ref_009","doi-asserted-by":"crossref","unstructured":"9. T. Peng, Y. Wang, T. Yang, F. Wang, J. Luo and Y. Zhang, Physiological and biochemical responses, and comparative transcriptome profiling of two Angelica sinensis cultivars under enhanced ultra-violet-B radiation, Front Plant. Sci. 12 (2021) Article ID 805407 (18 pages); https:\/\/doi.org\/10.3389\/fpls.2021.805407871892034975996","DOI":"10.3389\/fpls.2021.805407"},{"key":"2026051108200792036_j_acph-2023-0009_ref_010","doi-asserted-by":"crossref","unstructured":"10. Y. Zhang, Z. Li, K. Zhang, G. Yang, Z. Wang, J. Zhao, R. Hu and N. Feng, Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles, Int. J. Pharm. 511(1) (2016) 57\u201364; https:\/\/doi.org\/10.1016\/j.ijpharm.2016.06.13127374194","DOI":"10.1016\/j.ijpharm.2016.06.131"},{"key":"2026051108200792036_j_acph-2023-0009_ref_011","doi-asserted-by":"crossref","unstructured":"11. R. F. S. Gon\u00e7alves, J. T. Martins, L. Abrunhosa, J. Baixinho, A. A. Matias, A. A. Vicente and A. C. Pinheiro, Lipid-based nanostructures as a strategy to enhance curcumin bioaccessibility: Behavior under digestion and cytotoxicity assessment, Food Res. Int. 143 (2021) Article ID 110278; https:\/\/doi.org\/10.1016\/j.foodres.2021.11027833992378","DOI":"10.1016\/j.foodres.2021.110278"},{"key":"2026051108200792036_j_acph-2023-0009_ref_012","doi-asserted-by":"crossref","unstructured":"12. E. T. Rodrigues, S. F. Nascimento, C. L. Pires, L. P. Godinho, C. Churro, M. J. Moreno and M. A. Pardal, Determination of intestinal absorption of the paralytic shellfish toxin GTX-5 using the Caco-2 human cell model, Environ. Sci. Pollut Res. Int. 28(47) (2021) 67256\u201367266; https:\/\/doi.org\/10.1007\/s11356-021-15342-y34247356","DOI":"10.1007\/s11356-021-15342-y"},{"key":"2026051108200792036_j_acph-2023-0009_ref_013","doi-asserted-by":"crossref","unstructured":"13. S. Youhanna and V. M. Lauschke, The past, present and future of intestinal in vitro cell systems for drug absorption studies, J. Pharm. Sci. 110(1) (2021) 50\u201365; https:\/\/doi.org10.1016\/j.xphs.2020.07.00110.1016\/j.xphs.2020.07.001","DOI":"10.1016\/j.xphs.2020.07.001"},{"key":"2026051108200792036_j_acph-2023-0009_ref_014","doi-asserted-by":"crossref","unstructured":"14. R. Hu, S. Liu, G. Anwaier, Q. Wang, W. Shen, Q. Shen and R. Qi, Formulation and intestinal absorption of naringenin loaded nanostructured lipid carrier and its inhibitory effects on nonalcoholic fatty liver disease, Nanomedicine 32 (2021) Article ID 102310; https:\/\/doi.org\/10.1016\/j.nano.2020.10231033184021","DOI":"10.1016\/j.nano.2020.102310"},{"key":"2026051108200792036_j_acph-2023-0009_ref_015","doi-asserted-by":"crossref","unstructured":"15. Q. Yu, X. Hu, Y. Ma, Y. Xie, Y. Lu, J. Qi, L. Xiang, F. Li and W. Wu, Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus, Drug Deliv. 23(4) (2016) 1469\u20131475; https:\/\/doi.org\/10.3109\/10717544.2016.115374427187522","DOI":"10.3109\/10717544.2016.1153744"},{"key":"2026051108200792036_j_acph-2023-0009_ref_016","doi-asserted-by":"crossref","unstructured":"16. J. Akbari, M. Saeedi, F. Ahmadi, S. Hashemi, A. Babaei, S. Yaddollahi, S. S. Rostamkalaei, K. Asare-Addo and A. Nokhodchi, Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration, Pharm. Dev. Technol. 27(5) (2022) 525\u2013544; https:\/\/doi.org\/10.1080\/10837450.2022.208455435635506","DOI":"10.1080\/10837450.2022.2084554"},{"key":"2026051108200792036_j_acph-2023-0009_ref_017","doi-asserted-by":"crossref","unstructured":"17. Z. Cheng, Y. Li, K. Wang, X. Zhu, P. Tharkar, W. Shu, T. Zhang, S. Zeng, L. Zhu, M. Murray, W. Chrzanowski and F. Zhou, Compritol solid lipid nanoparticle formulations enhance the protective effect of betulinic acid derivatives in human M\u00fcller cells against oxidative injury, Exp. Eye Res. 215 (2022) Article ID 108906; https:\/\/doi.org\/10.1016\/j.exer.2021.10890634953864","DOI":"10.1016\/j.exer.2021.108906"},{"key":"2026051108200792036_j_acph-2023-0009_ref_018","doi-asserted-by":"crossref","unstructured":"18. V. Pokharkar, A. Patil-Gadhe and G. Kaur, Physicochemical and pharmacokinetic evaluation of rosuvastatin loaded nanostructured lipid carriers: influence of long- and medium-chain fatty acid mixture, J. Pharm. Investig. 48 (2018) 465\u2013476; https:\/\/doi.org\/10.1007\/s40005-017-0342-8","DOI":"10.1007\/s40005-017-0342-8"},{"key":"2026051108200792036_j_acph-2023-0009_ref_019","doi-asserted-by":"crossref","unstructured":"19. H. Shete, S. Chatterjee, A. De and V. Patravale, Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies, Int. J. Pharm. 454(1) (2013) 584\u2013592; https:\/\/doi.org\/10.1016\/j.ijpharm.2013.03.03623535344","DOI":"10.1016\/j.ijpharm.2013.03.036"},{"key":"2026051108200792036_j_acph-2023-0009_ref_020","doi-asserted-by":"crossref","unstructured":"20. P. Ganesan, P. Ramalingam, G. Karthivashan, Y. T. Ko and D. K. Choi, Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases, Int. J. Nanomedicine 13 (2018) 1569\u20131583; https:\/\/doi.org\/10.2147\/IJN.S155593585881929588585","DOI":"10.2147\/IJN.S155593"},{"key":"2026051108200792036_j_acph-2023-0009_ref_021","doi-asserted-by":"crossref","unstructured":"21. M. Elmowafy, K. Shalaby, H. M. Ali, N. K. Alruwaili, A. Salama, M. F. Ibrahim, M. A. Akl and T. A. Ahmed, Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies, Int. J. Pharm. 572 (2019) Article ID 118781; https:\/\/doi.org\/10.1016\/j.ijpharm.2019.11878131715347","DOI":"10.1016\/j.ijpharm.2019.118781"},{"key":"2026051108200792036_j_acph-2023-0009_ref_022","doi-asserted-by":"crossref","unstructured":"22. S. Haddadzadegan, F. Dorkoosh and A. Bernkop-Schn\u00fcrch, Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers, Adv. Drug Deliv. Rev. 182 (2022) Article ID 114097 (26 pages); https:\/\/doi.org\/10.1016\/j.addr.2021.11409734999121","DOI":"10.1016\/j.addr.2021.114097"},{"key":"2026051108200792036_j_acph-2023-0009_ref_023","doi-asserted-by":"crossref","unstructured":"23. Y. Zhang, Z. Li, K. Zhang, G. Yang, Z. Wang, J. Zhao, R. Hu and N. Feng, Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid as compared with conventional solid lipid nanoparticles, Int. J. Pharm. 511(1) (2016) 57\u201364; https:\/\/doi.org\/10.1016\/j.ijpharm.2016.06.13127374194","DOI":"10.1016\/j.ijpharm.2016.06.131"},{"key":"2026051108200792036_j_acph-2023-0009_ref_024","doi-asserted-by":"crossref","unstructured":"24. L. Zhou, Y. Chen, Z. Zhang, J. He, M. Du and Q. Wu, Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine, Pharmazie 67(4) (2012) 304\u2013310; https:\/\/doi.org\/10.1691\/ph.2012.1108","DOI":"10.31083\/ph.2012.1108"},{"key":"2026051108200792036_j_acph-2023-0009_ref_025","doi-asserted-by":"crossref","unstructured":"25. H. S. Rahman, A. Rasedee, H. H. Othman, M. S. Chartrand, F. Namvar, S. K. Yeap, N. Abdul Samad, R. J. Andas, N. Muhammad Nadzri, T. Anasamy, K. B. Ng and C. W. How, Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB\/c mice model, Biomed. Res. Int. 2014 (2014) Article ID 563930 (15 pages); https:\/\/doi.org\/10.1155\/2014\/563930417292425276798","DOI":"10.1155\/2014\/563930"},{"key":"2026051108200792036_j_acph-2023-0009_ref_026","doi-asserted-by":"crossref","unstructured":"26. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 70(2) (2008) 633\u2013640; https:\/\/doi.org\/10.1016\/j.ejpb.2008.05.00818577447","DOI":"10.1016\/j.ejpb.2008.05.008"},{"key":"2026051108200792036_j_acph-2023-0009_ref_027","doi-asserted-by":"crossref","unstructured":"27. L. P. Mendes, J. M. F. Delgado, A. D. A. Costa, M. S. Vieira, P. L. Benfica, E. M. Lima and M. C. Valadares, Biodegradable nanoparticles designed for drug delivery: the number of nanoparticles impacts on cytotoxicity, Toxicol. in Vitro 29(6) (2015) 1268\u20131274; https:\/\/doi.org\/10.1016\/j.tiv.2014.12.02125596133","DOI":"10.1016\/j.tiv.2014.12.021"},{"key":"2026051108200792036_j_acph-2023-0009_ref_028","doi-asserted-by":"crossref","unstructured":"28. N. V. Shah, A. K. Seth, R. Balaraman, C. J. Aundhia, R. A. Maheshwari and G. R. Parmar, Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study, J. Adv. Res. 7(3) (2016) 423\u2013434; https:\/\/doi.org\/10.1016\/j.jare.2016.03.002485683627222747","DOI":"10.1016\/j.jare.2016.03.002"},{"key":"2026051108200792036_j_acph-2023-0009_ref_029","doi-asserted-by":"crossref","unstructured":"29. A. Beloqui, M. \u00c1. Solin\u00eds, A. R. Gasc\u00f3n, A. del Pozo-Rodr\u00edguez, A. des Rieux and V. Pr\u00e9at, Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier, J. Control. Release 166(2) (2013) 115\u2013123; https:\/\/doi.org\/10.1016\/j.jconrel.2012.12.02123266764","DOI":"10.1016\/j.jconrel.2012.12.021"},{"key":"2026051108200792036_j_acph-2023-0009_ref_030","doi-asserted-by":"crossref","unstructured":"30. A. Ali Khan, J. Mudassir, N. Mohtar and Y. Darwis, Advanced drug delivery to the lymphatic system: lipid-based nanoformulations, Int. J. Nanomedicine 8(1) (2013) 2733\u20132744; https:\/\/doi.org\/10.2147\/IJN.S41521373220123926431","DOI":"10.2147\/IJN.S41521"},{"key":"2026051108200792036_j_acph-2023-0009_ref_031","doi-asserted-by":"crossref","unstructured":"31. X. Zhou, X. Zhang, Y. Ye, T. Zhang, H. Wang, Z. Ma and B. Wu, Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption, Int. J. Pharm. 479(2) (2015) 391\u2013398; https:\/\/doi.org\/10.1016\/j.ijpharm.2014.12.06825556104","DOI":"10.1016\/j.ijpharm.2014.12.068"},{"key":"2026051108200792036_j_acph-2023-0009_ref_032","doi-asserted-by":"crossref","unstructured":"32. R. Ghadi and N. Dand, BCS class IV drugs: Highly notorious candidates for formulation development, J. Control. Release 248 (2017) 71\u201395; https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.01428088572","DOI":"10.1016\/j.jconrel.2017.01.014"},{"key":"2026051108200792036_j_acph-2023-0009_ref_033","doi-asserted-by":"crossref","unstructured":"33. V. Makwana, R. Jain, K. Patel, M. Nivsarkar and A. Joshi, Solid lipid nanoparticles (SLN) of efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach, Int. J. Pharm. 495(1) (2015) 439\u2013446; https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.01426367780","DOI":"10.1016\/j.ijpharm.2015.09.014"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2023-0009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:34:29Z","timestamp":1778488469000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2023-0009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,24]]},"published-print":{"date-parts":[[2023,3,1]]}},"alternative-id":["10.2478\/acph-2023-0009"],"URL":"https:\/\/doi.org\/10.2478\/acph-2023-0009","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}